Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 145 to 149 of 149 entries
Sorted by: Best Match Show Resources per page
Brain Biopsy for Neurological Diseases of Unknown Etiology in Critically Ill Patients: Feasibility, Safety, and Diagnostic Yield.

Critical care medicine

Mathon B, Favreau M, Degos V, Amelot A, Le Joncour A, Weiss N, Rohaut B, Le Guennec L, Boch AL, Carpentier A, Bielle F, Mokhtari K, Idbaih A, Touat M, Combes A, Demoule A, Shotar E, Navarro V, Raux M, Demeret S, Pineton De Chambrun M.
PMID: 34995211
Crit Care Med. 2022 Jan 10; doi: 10.1097/CCM.0000000000005439. Epub 2022 Jan 10.

OBJECTIVES: Brain biopsy is a useful surgical procedure in the management of patients with suspected neoplastic lesions. Its role in neurologic diseases of unknown etiology remains controversial, especially in ICU patients. This study was undertaken to determine the feasibility,...

Cite
Mathon B, Favreau M, Degos V, et al. Brain Biopsy for Neurological Diseases of Unknown Etiology in Critically Ill Patients: Feasibility, Safety, and Diagnostic Yield. Crit Care Med. 2022;doi: 10.1097/CCM.0000000000005439.
Mathon, B., Favreau, M., Degos, V., Amelot, A., Le Joncour, A., Weiss, N., Rohaut, B., Le Guennec, L., Boch, A. L., Carpentier, A., Bielle, F., Mokhtari, K., Idbaih, A., Touat, M., Combes, A., Demoule, A., Shotar, E., Navarro, V., Raux, M., Demeret, S., Pineton De Chambrun, M. (2022). Brain Biopsy for Neurological Diseases of Unknown Etiology in Critically Ill Patients: Feasibility, Safety, and Diagnostic Yield. Critical care medicine, . https://doi.org/10.1097/CCM.0000000000005439
Mathon, Bertrand, et al. "Brain Biopsy for Neurological Diseases of Unknown Etiology in Critically Ill Patients: Feasibility, Safety, and Diagnostic Yield." Critical care medicine vol. (2022). doi: https://doi.org/10.1097/CCM.0000000000005439
Mathon B, Favreau M, Degos V, Amelot A, Le Joncour A, Weiss N, Rohaut B, Le Guennec L, Boch AL, Carpentier A, Bielle F, Mokhtari K, Idbaih A, Touat M, Combes A, Demoule A, Shotar E, Navarro V, Raux M, Demeret S, Pineton De Chambrun M. Brain Biopsy for Neurological Diseases of Unknown Etiology in Critically Ill Patients: Feasibility, Safety, and Diagnostic Yield. Crit Care Med. 2022 Jan 10; doi: 10.1097/CCM.0000000000005439. Epub 2022 Jan 10. PMID: 34995211.
Copy Download .nbib Format: NLM
Challenging Cosmetic Innovation: The Skin Microbiota and Probiotics Protect the Skin from UV-Induced Damage.

Microorganisms

Souak D, Barreau M, Courtois A, André V, Duclairoir Poc C, Feuilloley MGJ, Gault M.
PMID: 33925587
Microorganisms. 2021 Apr 27;9(5). doi: 10.3390/microorganisms9050936.

Many studies performed in the last decade have focused on the cutaneous microbiota. It has been shown that this microbiota plays a key role in skin homeostasis. Considered as "a second barrier" to the environment, it is very important...

Cite
Souak D, Barreau M, Courtois A, et al. Challenging Cosmetic Innovation: The Skin Microbiota and Probiotics Protect the Skin from UV-Induced Damage. Microorganisms. 2021;9(5)doi: 10.3390/microorganisms9050936.
Souak, D., Barreau, M., Courtois, A., André, V., Duclairoir Poc, C., Feuilloley, M. G. J., & Gault, M. (2021). Challenging Cosmetic Innovation: The Skin Microbiota and Probiotics Protect the Skin from UV-Induced Damage. Microorganisms, 9(5), . https://doi.org/10.3390/microorganisms9050936
Souak, Djouhar, et al. "Challenging Cosmetic Innovation: The Skin Microbiota and Probiotics Protect the Skin from UV-Induced Damage." Microorganisms vol. 9,5 (2021). doi: https://doi.org/10.3390/microorganisms9050936
Souak D, Barreau M, Courtois A, André V, Duclairoir Poc C, Feuilloley MGJ, Gault M. Challenging Cosmetic Innovation: The Skin Microbiota and Probiotics Protect the Skin from UV-Induced Damage. Microorganisms. 2021 Apr 27;9(5). doi: 10.3390/microorganisms9050936. PMID: 33925587; PMCID: PMC8145394.
Copy Download .nbib Format: NLM
Achieving high circularly polarized luminescence with push-pull helicenic systems: from rationalized design to top-emission CP-OLED applications.

Chemical science

Dhbaibi K, Abella L, Meunier-Della-Gatta S, Roisnel T, Vanthuyne N, Jamoussi B, Pieters G, Racine B, Quesnel E, Autschbach J, Crassous J, Favereau L.
PMID: 34163772
Chem Sci. 2021 Mar 02;12(15):5522-5533. doi: 10.1039/d0sc06895k.

While the development of chiral molecules displaying circularly polarized luminescence (CPL) has received considerable attention, the corresponding CPL intensity,

Cite
Dhbaibi K, Abella L, Meunier-Della-Gatta S, et al. Achieving high circularly polarized luminescence with push-pull helicenic systems: from rationalized design to top-emission CP-OLED applications. Chem Sci. 2021;12(15):5522-5533doi: 10.1039/d0sc06895k.
Dhbaibi, K., Abella, L., Meunier-Della-Gatta, S., Roisnel, T., Vanthuyne, N., Jamoussi, B., Pieters, G., Racine, B., Quesnel, E., Autschbach, J., Crassous, J., & Favereau, L. (2021). Achieving high circularly polarized luminescence with push-pull helicenic systems: from rationalized design to top-emission CP-OLED applications. Chemical science, 12(15), 5522-5533. https://doi.org/10.1039/d0sc06895k
Dhbaibi, Kais, et al. "Achieving high circularly polarized luminescence with push-pull helicenic systems: from rationalized design to top-emission CP-OLED applications." Chemical science vol. 12,15 (2021): 5522-5533. doi: https://doi.org/10.1039/d0sc06895k
Dhbaibi K, Abella L, Meunier-Della-Gatta S, Roisnel T, Vanthuyne N, Jamoussi B, Pieters G, Racine B, Quesnel E, Autschbach J, Crassous J, Favereau L. Achieving high circularly polarized luminescence with push-pull helicenic systems: from rationalized design to top-emission CP-OLED applications. Chem Sci. 2021 Mar 02;12(15):5522-5533. doi: 10.1039/d0sc06895k. PMID: 34163772; PMCID: PMC8179576.
Copy Download .nbib Format: NLM
The Syndrome of Arthrogryposis and Palatoschisis (SAP) in Charolais cattle; Abnormal motor innervation and defect in the focalization of 16 S acetylcholinesterase in the end-plates rich regions of the muscle.

Annales de genetique et de selection animale

Rieger F, Pinçon-Raymond M, Dreyfus P, Guittard M, Fardeau M.
PMID: 22896145
Ann Genet Sel Anim. 1979;11(4):371-80. doi: 10.1186/1297-9686-11-4-371.

No abstract available.

Cite
Rieger F, Pinçon-Raymond M, Dreyfus P, et al. The Syndrome of Arthrogryposis and Palatoschisis (SAP) in Charolais cattle; Abnormal motor innervation and defect in the focalization of 16 S acetylcholinesterase in the end-plates rich regions of the muscle. Ann Genet Sel Anim. 1979;11(4):371-80doi: 10.1186/1297-9686-11-4-371.
Rieger, F., Pinçon-Raymond, M., Dreyfus, P., Guittard, M., & Fardeau, M. (1979). The Syndrome of Arthrogryposis and Palatoschisis (SAP) in Charolais cattle; Abnormal motor innervation and defect in the focalization of 16 S acetylcholinesterase in the end-plates rich regions of the muscle. Annales de genetique et de selection animale, 11(4), 371-80. https://doi.org/10.1186/1297-9686-11-4-371
Rieger, F, et al. "The Syndrome of Arthrogryposis and Palatoschisis (SAP) in Charolais cattle; Abnormal motor innervation and defect in the focalization of 16 S acetylcholinesterase in the end-plates rich regions of the muscle." Annales de genetique et de selection animale vol. 11,4 (1979): 371-80. doi: https://doi.org/10.1186/1297-9686-11-4-371
Rieger F, Pinçon-Raymond M, Dreyfus P, Guittard M, Fardeau M. The Syndrome of Arthrogryposis and Palatoschisis (SAP) in Charolais cattle; Abnormal motor innervation and defect in the focalization of 16 S acetylcholinesterase in the end-plates rich regions of the muscle. Ann Genet Sel Anim. 1979;11(4):371-80. doi: 10.1186/1297-9686-11-4-371. PMID: 22896145; PMCID: PMC2718941.
Copy Download .nbib Format: NLM
New structural variations responsible for Charcot-Marie-Tooth disease: The first two large .

Computational and structural biotechnology journal

Pyromali I, Perani A, Nizou A, Benslimane N, Derouault P, Bourthoumieu S, Fradin M, Sole G, Duval F, Gomes C, Favreau F, Sturtz F, Magdelaine C, Lia AS.
PMID: 34429846
Comput Struct Biotechnol J. 2021 Jul 30;19:4265-4272. doi: 10.1016/j.csbj.2021.07.037. eCollection 2021.

Next-generation sequencing (NGS) allows the detection of mutations in inherited genetic diseases, like the Charcot-Marie-Tooth disease (CMT) which is the most common hereditary peripheral neuropathy. The majority of mutations detected by NGS are single nucleotide variants (SNVs) or small...

Cite
Pyromali I, Perani A, Nizou A, et al. New structural variations responsible for Charcot-Marie-Tooth disease: The first two large . Comput Struct Biotechnol J. 2021;19:4265-4272doi: 10.1016/j.csbj.2021.07.037.
Pyromali, I., Perani, A., Nizou, A., Benslimane, N., Derouault, P., Bourthoumieu, S., Fradin, M., Sole, G., Duval, F., Gomes, C., Favreau, F., Sturtz, F., Magdelaine, C., & Lia, A. S. (2021). New structural variations responsible for Charcot-Marie-Tooth disease: The first two large . Computational and structural biotechnology journal, 194265-4272. https://doi.org/10.1016/j.csbj.2021.07.037
Pyromali, Ioanna, et al. "New structural variations responsible for Charcot-Marie-Tooth disease: The first two large ." Computational and structural biotechnology journal vol. 19 (2021): 4265-4272. doi: https://doi.org/10.1016/j.csbj.2021.07.037
Pyromali I, Perani A, Nizou A, Benslimane N, Derouault P, Bourthoumieu S, Fradin M, Sole G, Duval F, Gomes C, Favreau F, Sturtz F, Magdelaine C, Lia AS. New structural variations responsible for Charcot-Marie-Tooth disease: The first two large . Comput Struct Biotechnol J. 2021 Jul 30;19:4265-4272. doi: 10.1016/j.csbj.2021.07.037. eCollection 2021. PMID: 34429846; PMCID: PMC8355829.
Copy Download .nbib Format: NLM
Showing 145 to 149 of 149 entries